Kestra Advisory Services’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96K Sell
17,148
-2,192
-11% -$13.8K ﹤0.01% 3355
2026
Q2
$110K Buy
+19,340
New +$94.5K ﹤0.01% 3174
2026
Q1
– Sell
-7,916
Closed -$70.9K – 3983
2025
Q4
$70.9K Buy
+7,916
New +$49K ﹤0.01% 3700

Other funds holding NUVB

Kestra Advisory Services's NUVB Position: Q3 2026 in Review

Kestra Advisory Services reduced its Nuvation Bio (NUVB) stake by 11% in Q3 2026, selling an estimated $13.8K and leaving 17,148 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #3355.

Kestra Advisory Services first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $110K in Q2 2026. 254 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Kestra Advisory Services held 17,148 shares of Nuvation Bio worth $96K as of Q3 2026.
  • Kestra Advisory Services sold 2,192 Nuvation Bio shares in Q3 2026, an estimated $13.8K.
  • Nuvation Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3355 holding.
  • Kestra Advisory Services first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • Kestra Advisory Services's Nuvation Bio position peaked at $110K in Q2 2026.
  • 254 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.